-+ 0.00%
-+ 0.00%
-+ 0.00%

FIBROBIOLOGICS ANNOUNCES FIRST PATIENTS DOSED IN PHASE 1/2 CLINICAL TRIAL EVALUATING CYWC628 FOR THE TREATMENT OF DIABETIC FOOT ULCERS

Reuters·06/03/2026 11:00:01

Please log in to view news